These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 28522266)

  • 21. Regulating Chemokine-Receptor Interactions through the Site-Specific Bioorthogonal Conjugation of Photoresponsive DNA Strands.
    van Stevendaal MHME; Hazegh Nikroo A; Mason AF; Jansen J; Yewdall NA; van Hest JCM
    Bioconjug Chem; 2023 Nov; 34(11):2089-2095. PubMed ID: 37856672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and incorporation of a caged tyrosine amino acid possessing a bioorthogonal handle.
    Padilla MS; Farley CA; Chatkewitz LE; Young DD
    Tetrahedron Lett; 2016 Oct; 57(42):4709-4712. PubMed ID: 28533567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Yield Site-Specific Conjugation of Fibroblast Growth Factor 1 with Monomethylauristatin E via Cysteine Flanked by Basic Residues.
    Lobocki M; Zakrzewska M; Szlachcic A; Krzyscik MA; Sokolowska-Wedzina A; Otlewski J
    Bioconjug Chem; 2017 Jul; 28(7):1850-1858. PubMed ID: 28598150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Method for Preparation of Site-Specific, Stoichiometric-Controlled Dual Warhead Conjugate of FGF2 via Dimerization Employing Sortase A-Mediated Ligation.
    Krzyscik MA; Opaliński Ł; Otlewski J
    Mol Pharm; 2019 Aug; 16(8):3588-3599. PubMed ID: 31244217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.
    He J; Zeng X; Wang C; Wang E; Li Y
    MedComm (2020); 2024 Aug; 5(8):e671. PubMed ID: 39070179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-Warhead Conjugate Based on Fibroblast Growth Factor 2 Dimer Loaded with α-Amanitin and Monomethyl Auristatin E Exhibits Superior Cytotoxicity towards Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1.
    Nawrocka D; Krzyscik MA; Sluzalska KD; Otlewski J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model.
    Krzyscik MA; Zakrzewska M; Sørensen V; Øy GF; Brunheim S; Haugsten EM; Mælandsmo GM; Wiedlocha A; Otlewski J
    Biomacromolecules; 2021 Oct; 22(10):4169-4180. PubMed ID: 34542998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1).
    Krzyscik MA; Zakrzewska M; Otlewski J
    Mol Pharm; 2020 Jul; 17(7):2734-2748. PubMed ID: 32501706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-Specific Labeling of Proteins Using Unnatural Amino Acids.
    Lee KJ; Kang D; Park HS
    Mol Cells; 2019 May; 42(5):386-396. PubMed ID: 31122001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment.
    Porębska N; Latko M; Kucińska M; Zakrzewska M; Otlewski J; Opaliński Ł
    J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30577533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity.
    Chudzian J; Szlachcic A; Zakrzewska M; Czub M; Pustula M; Holak TA; Otlewski J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF2 Dual Warhead Conjugate with Monomethyl Auristatin E and α-Amanitin Displays a Cytotoxic Effect towards Cancer Cells Overproducing FGF Receptor 1.
    Świderska KW; Szlachcic A; Opaliński Ł; Zakrzewska M; Otlewski J
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition.
    Pickens CJ; Johnson SN; Pressnall MM; Leon MA; Berkland CJ
    Bioconjug Chem; 2018 Mar; 29(3):686-701. PubMed ID: 29287474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific conjugation of fibroblast growth factor 2 (FGF2) based on incorporation of alkyne-reactive unnatural amino acid.
    Swiderska KW; Szlachcic A; Czyrek A; Zakrzewska M; Otlewski J
    Bioorg Med Chem; 2017 Jul; 25(14):3685-3693. PubMed ID: 28522266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper Catalysis in Living Systems and In Situ Drug Synthesis.
    Clavadetscher J; Hoffmann S; Lilienkampf A; Mackay L; Yusop RM; Rider SA; Mullins JJ; Bradley M
    Angew Chem Int Ed Engl; 2016 Dec; 55(50):15662-15666. PubMed ID: 27860120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerating Strain-Promoted Azide-Alkyne Cycloaddition Using Micellar Catalysis.
    Anderton GI; Bangerter AS; Davis TC; Feng Z; Furtak AJ; Larsen JO; Scroggin TL; Heemstra JM
    Bioconjug Chem; 2015 Aug; 26(8):1687-91. PubMed ID: 26056848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of copper-catalyzed azide-alkyne cycloaddition for increased in vivo efficacy of interferon β-1b by site-specific PEGylation.
    Nairn NW; Shanebeck KD; Wang A; Graddis TJ; VanBrunt MP; Thornton KC; Grabstein K
    Bioconjug Chem; 2012 Oct; 23(10):2087-97. PubMed ID: 22988919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliable and efficient procedures for the conjugation of biomolecules through Huisgen azide-alkyne cycloadditions.
    Lallana E; Riguera R; Fernandez-Megia E
    Angew Chem Int Ed Engl; 2011 Sep; 50(38):8794-804. PubMed ID: 21905176
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.